Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.258.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.319NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.182NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.430NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.331NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.112.3 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.176NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.3.4 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.391NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.393NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.432NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.388NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.48NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.112NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.274NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.515NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.450NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.130NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.444NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
AW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.268NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.344NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.103NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.485NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.119NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.276NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
L.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.310NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.185NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.329NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.229NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.342NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.90NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.169NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.53NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.513NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.338NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.284NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.9.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.498NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.184NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.187NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
D.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used